Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Late-onset, Insidious Course and Invasive Treatment of Congenital Central Hypoventilation Syndrome in a Case With the Phox2B Mutation

NCT01225679 is registered in ClinicalTrials.gov with Associação Fundo de Incentivo à Pesquisa as lead sponsor.

NCT NCT01225679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Late-onset, Insidious Course and Invasive Treatment of Congenital Central Hypoventilation Syndrome in a Case With the Phox2B Mutation
Lead sponsor
Associação Fundo de Incentivo à Pesquisa
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
September 30, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital central hypoventilation syndrome